No Data
No Data
Live Stock News: -2.8% GDP, Trade War Sends Market Lower, Tesla Sales Punished
Live Stock News: Chips Falling Alongside Crypto Despite Trump Money News-- the Honeymoon is Over
Biogen's Alzheimer's Treatment Lecanemab Denied Approval in Australia
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia
Play Defense With Goldman's Cheap Healthcare Picks
Wall Street Today: Market Ends Wild Political TV Day in the Green
72886030 : any thoughts why it is dropping after the earnings?
thoughtful Bat_8163 OP 72886030 : forecast? To be honest, it is really disappointing regarding Leqembi rollout. BIIB has betted huge on it. I was expecting much better quarter over quarter growth
72886030 thoughtful Bat_8163 OP : thanks for sharing. hope all the bad news are priced in now.